Ali McBride

3.9k citations

234 papers · 2.7k indexed · h-index 28

Impact in

Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Neutropenia and Cancer Infections
Hematology top 2%
- Hematopoietic Stem Cell Transplantation

Papers in ⓘ

Hematology 64
- Acute Myeloid Leukemia Research 27
Genetics 51
- Chronic Lymphocytic Leukemia Research 28

Co-authors: Ivo Abraham (84 shared papers)Faiz Anwer (35 shared papers)Marion Slack (18 shared papers)Brian L. Erstad (16 shared papers)Peter Westervelt (4 shared papers)Karen MacDonald (24 shared papers)Abdulaali R. Almutairi (13 shared papers)Hani M. Babiker (23 shared papers)
Journals: Journal of Clinical Oncology (39 papers)Blood (28 papers)Journal of Medical Economics (16 papers)Biology of Blood and Marrow Transplantation (12 papers)Future Oncology (10 papers)
Partner nations: United States United Kingdom Saudi Arabia

In The Last Decade

Ali McBride

209 papers receiving 2.6k citations

Peers

Countries citing papers authored by Ali McBride

Since Specialization

Citations

This map shows the geographic impact of Ali McBride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali McBride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali McBride more than expected).

Fields of papers citing papers by Ali McBride

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali McBride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali McBride. The network helps show where Ali McBride may publish in the future.

Co-authors

The 25 scholars most cited alongside Ali McBride, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ali McBride Line = papers co-authored together Ali McBride links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 234 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation Biology of Blood and Marrow Transplantation ·Awais Ijaz, Ali Younas Khan, Saad Ullah Malik, Warda Faridi, Muhammad Asad Fraz, Muhammad Usman, Muhammad Junaid Tariq, Seren Durer, Ceren Durer, Atlantis Dawn Russ, Nadia Nunes Cavalcante Parr, Zeeshan Baig, Fnu Sagar, Zeeshan Ali, Ali McBride, Faiz Anwer	2018	127
2	Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review and Meta-Analysis Frontiers in Oncology ·Abdulaali R. Almutairi, Ali McBride, Marion Slack, Brian L. Erstad, Ivo Abraham	2020	125
3	The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta‐analysis The Prostate ·Mok Oh, Nasser Alkhushaym, Saad Fallatah, Abdulhamid Althagafi, Rana Aljadeed, Yazed Saleh Alsowaida, Joanne Jeter, Jennifer Martin, Hani M. Babiker, Ali McBride, Ivo Abraham	2019	90
4	Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review Annals of Hematology ·Scott C. Howard, Steven Trifilio, Tara Gregory, Nadine Baxter, Ali McBride	2016	86
5	BRCA1andBRCA2Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis JNCI Journal of the National Cancer Institute ·Mok Oh, Ali McBride, Seongseok Yun, Sandipan Bhattacharjee, Marion Slack, Jennifer Martin, Joanne Jeter, Ivo Abraham	2018	86
6	Angiosarcoma treated successfully with anti-PD-1 therapy - a case report Journal for ImmunoTherapy of Cancer ·Simran Sindhu, Lana H. Gimber, Lee D. Cranmer, Ali McBride, Andrew S. Kraft	2017	83
7	National survey on the effect of oncology drug shortages on cancer care American Journal of Health-System Pharmacy ·Ali McBride, Lisa M. Holle, Colleen Westendorf, Margaret Sidebottom, Niesha Griffith, Raymond J. Muller, James M. Hoffman	2013	83
8	Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system Critical Reviews in Oncology/Hematology ·Hani M. Babiker, Ali McBride, Michael Newton, Leigh Boehmer, Adrienne Drucker, Mollie Gowan, Manouchkathe Cassagnol, Todd D. Camenisch, Faiz Anwer, James M. Hollands	2018	78
9	Donor Origin CAR T Cells: Graft Versus Malignancy Effect Without GVHD, a Systematic Review Immunotherapy ·Faiz Anwer, Al-Aman Shaukat, Umar Zahid, Muhammad Husnain, Ali McBride, Daniel O. Persky, Melissa Siaw Han Lim, Nida Hasan, Irbaz Bin Riaz	2017	74
10	A Review of Autologous Stem Cell Transplantation in Lymphoma Current Hematologic Malignancy Reports ·Umar Zahid, Faisal Akbar, Akshay Amaraneni, Muhammad Husnain, Onyee Chan, Irbaz Bin Riaz, Ali McBride, Ahmad Iftikhar, Faiz Anwer	2017	61
11	Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies Journal of Hematology & Oncology ·Ali McBride, Peter Westervelt	2012	56
12	Brentuximab vedotin for treatment of non-Hodgkin lymphomas: A systematic review Critical Reviews in Oncology/Hematology ·Garrett K. Berger, Ali McBride, Stephanie Lawson, Kelsey Royball, Seongseok Yun, Kevin Gee, Irbaz Bin Riaz, Ahlam Saleh, Soham D. Puvvada, Faiz Anwer	2016	54
13	Carfilzomib: A second-generation proteasome inhibitor for the treatment of multiple myeloma American Journal of Health-System Pharmacy ·Ali McBride, Jeff O. Klaus, Keith Stockerl‐Goldstein	2015	51
14	Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblast Leukemia: A Systematic Review Biology of Blood and Marrow Transplantation ·Zabih Warraich, Pavan Tenneti, Theresa Thai, Anne Hubben, Hina Amin, Ali McBride, Sami Ullah, Abdul Hannan, Faiza Hassan Warraich, Navneet S. Majhail, Matt Kalaycio, Faiz Anwer	2019	45
15	Global Acceptance of Biosimilars: Importance of Regulatory Consistency, Education, and Trust The Oncologist ·Eduardo Cazap, Ira Jacobs, Ali McBride, Robert Popovian, Karol Sikora	2018	40
16	Eribulin mesylate: A novel halichondrin B analogue for the treatment of metastatic breast cancer American Journal of Health-System Pharmacy ·Ali McBride, Sara K. Butler	2012	40
17	Proteasome inhibitors in the treatment of multiple myeloma Expert Review of Anticancer Therapy ·Ali McBride, Patricia Y. Ryan	2013	39
18	Board-Certified Oncology Pharmacists: Their Potential Contribution to Reducing a Shortfall in Oncology Patient Visits Journal of Oncology Practice ·Robert J. Ignoffo, Katherine K. Knapp, Mitchell J. Barnett, Sally Barbour, Steve D’Amato, Lew Iacovelli, Jasen Knudsen, Susannah E. Koontz, Robert Mancini, Ali McBride, Dayna L. McCauley, Patrick J. Medina, Cindy L. O’Bryant, Sarah L Scarpace, Steve Stricker, James A. Trovato	2016	37
19	Comparison of treatment patterns and economic outcomes among metastatic pancreatic cancer patients initiated on nab-paclitaxel plus gemcitabine versus FOLFIRINOX Expert Review of Clinical Pharmacology ·Ali McBride, Machaon Bonafede, Qian Cai, Nicole Princic, Oth Tran, Corey Pelletier, Monika Parisi, Manish Patel	2017	34
20	Perceived sensitivity of mammographic screening: women's views on test accuracy and financial compensation for missed cancers. Journal of Epidemiology & Community Health ·Alexandra Barratt, Jill Cockburn, C. M. Furnival, Ali McBride, Lena Mallon	1999	33

About Ali McBride

Ali McBride is a scholar working on Hematology, Genetics, Oncology, Internal Medicine and Economics and Econometrics, having authored 234 papers that have together received 2.7k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (46 papers), Economic and Financial Impacts of Cancer (29 papers), Chronic Lymphocytic Leukemia Research (28 papers), Acute Myeloid Leukemia Research (27 papers), Biosimilars and Bioanalytical Methods (25 papers), Lymphoma Diagnosis and Treatment (23 papers), Health Systems, Economic Evaluations, Quality of Life (21 papers) and CAR-T cell therapy research (20 papers). The work is most often cited by research in Oncology (1.4k citations), Hematology (480 citations), Immunology (534 citations), Genetics (263 citations) and Pathology and Forensic Medicine (346 citations). Ali McBride has collaborated with scholars based in United States, United Kingdom and Saudi Arabia. Frequent co-authors include Ivo Abraham, Faiz Anwer, Marion Slack, Brian L. Erstad, Peter Westervelt, Karen MacDonald, Abdulaali R. Almutairi, Hani M. Babiker, Jennifer Martin and Irbaz Bin Riaz. Their work appears in journals such as Journal of Clinical Oncology, Blood, Journal of Medical Economics, Biology of Blood and Marrow Transplantation and Future Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact